Posizolid

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Posizolid
Posizolid.png
Clinical data
ATC code
  • none
Identifiers
Synonyms AZD2563
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard 100.234.485
Chemical and physical data
Formula C21H21F2N3O7
Molar mass 465.40 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]

Clinical trials[edit]

References[edit]

  1. ^ Wookey, A.; Turner, P. J.; Greenhalgh, J. M.; Eastwood, M.; Clarke, J.; Sefton, C. (2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247–254. doi:10.1111/j.1198-743X.2004.00770.x. PMID 15008947.